Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-L1 and PD-L2 Peptide Vaccination as Consolidation for Relapsed Follicular Lymphoma

NCT03381768 is registered in ClinicalTrials.gov with Lars Møller Pedersen as lead sponsor.

NCT NCT03381768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03381768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-L1 and PD-L2 Peptide Vaccination as Consolidation for Relapsed Follicular Lymphoma
Lead sponsor
Lars Møller Pedersen
Phase
Phase 1
Overall status
Completed
Start date
December 12, 2017
Completion date
February 12, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma